Halozyme Therapeutics | Pasivo Circulante



Current Liabilities Cambio Fecha
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amarin USD 162.41M 17.54M 2025-03
Amgen USD 23.01B 91M 2025-03
Baxter International USD 3.48B 3.03B 2025-03
Cytokinetics USD 159.73M 19.95M 2025-03
DBV Technologies USD 40.38M 9.25M 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
MannKind USD 115.94M 34.1M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
United Therapeutics USD 527.1M 194.4M 2025-06


Halozyme Therapeutics Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.